Skip to main content
logo
Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
1.670
-0.100 (-5.65%)
At close: Oct 5, 2026, 4:00 PM EDT
1.710
+0.040 (2.40%)
Pre-market: Oct 6, 2026, 5:33 AM EDT

Decoy Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.23----1.84
Revenue Growth
------64.84%
Gross Profit
-1.63-----6.71
Operating Income
-6.1-4.1-5.73-12.89-22.98-12.81
Net Income
-14.45-12.52-5.58-12.54-31.61-12.77
Earnings Per Share
-40.40-129.10-69.54---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.2910.712.435.912.1129.21
Total Debt
--0.220.29--
Net Cash (Debt)
8.2910.712.215.6112.1129.21
Net Cash Growth
942.81%384.03%-60.56%-53.66%-58.56%174.53%
Net Cash Per Share
23.17110.4527.59---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.32-4.83-4.53-12.85-17.6-10.2
Capital Expenditures
-0.04-----
Free Cash Flow
-8.37-4.83-4.53-12.85-17.6-10.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-2679.30%-----696.27%
Pretax Margin
-6347.85%-----693.84%
Profit Margin
-6347.85%-----693.84%
FCF Margin
-3675.70%-----554.29%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.81----12.17